Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
5 12月 2018
UPC latest news
21 11月 2018
Competing class actions are again in the spotlight
15 11月 2018
Draft Withdrawal Agreement Approved by UK Cabinet – IP and Marketing Authorisation Provisions Summarised
9 11月 2018
What’s the damage? – The Federal Court’s decision in Sigma v Wyeth
9 11月 2018
ACCC to up the ante in consumer protection matters
8 11月 2018
Personalised Health and The Future of Pharma
25 10月 2018
ACCC’s challenge to Pfizer comes to the end of the road with the High Court
22 10月 2018
France adopts a confidentiality regime for the trade secrets relied upon in (patent) litigation
11 10月 2018
Patent and Pharma Update, October 2018
26 9月 2018
Brexit “no deal” technical notices published on intellectual property and life sciences sector issues
17 8月 2018
Compulsory Licences, Crown Use and Inventive Step – Future Changes to the Patents Act
1 8月 2018
Indonesia’s foreign investment regime liberalised by new OSS system
